1. Cell Biology
  2. Microbiology and Infectious Disease
Download icon

Sequestration of host metabolism by an intracellular pathogen

  1. Lena Gehre
  2. Olivier Gorgette
  3. Stéphanie Perrinet
  4. Marie-Christine Prevost
  5. Mathieu Ducatez
  6. Amanda M Giebel
  7. David E Nelson
  8. Steven G Ball
  9. Agathe Subtil  Is a corresponding author
  1. Institut Pasteur, France
  2. Université de Lille, France
  3. Indiana University Bloomington, United States
  4. Indiana University School of Medicine, United States
Research Article
  • Cited 39
  • Views 2,963
  • Annotations
Cite this article as: eLife 2016;5:e12552 doi: 10.7554/eLife.12552

Abstract

For intracellular pathogens, residence in a vacuole provides a shelter against cytosolic host defense to the cost of limited access to nutrients. The human pathogen Chlamydia trachomatis grows in a glycogen-rich vacuole. How this large polymer accumulates there is unknown. We reveal that host glycogen stores shift to the vacuole through two pathways: bulk uptake from the cytoplasmic pool, and de novo synthesis. We provide evidence that bacterial glycogen metabolism enzymes are secreted into the vacuole lumen through type 3 secretion. Our data bring strong support to the following scenario: bacteria co-opt the host transporter SLC35D2 to import UDP-glucose into the vacuole, where it serves as substrate for de novo glycogen synthesis, through a remarkable adaptation of the bacterial glycogen synthase. Based on these findings we propose that parasitophorous vacuoles not only offer protection but also provide a microorganism-controlled metabolically active compartment essential for redirecting host resources to the pathogens.

Article and author information

Author details

  1. Lena Gehre

    Unité de Biologie cellulaire de l'infection microbienne, Institut Pasteur, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  2. Olivier Gorgette

    Plate-forme de Microscopie Ultrastructurale, Institut Pasteur, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  3. Stéphanie Perrinet

    Unité de Biologie cellulaire de l'infection microbienne, Institut Pasteur, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  4. Marie-Christine Prevost

    Plate-forme de Microscopie Ultrastructurale, Institut Pasteur, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  5. Mathieu Ducatez

    Unité de Glycobiologie Structurale et Fonctionnelle, Université de Lille, Lille, France
    Competing interests
    The authors declare that no competing interests exist.
  6. Amanda M Giebel

    Department of Biology, Indiana University Bloomington, Bloomington, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. David E Nelson

    Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Steven G Ball

    Unité de Glycobiologie Structurale et Fonctionnelle, Université de Lille, Lille, France
    Competing interests
    The authors declare that no competing interests exist.
  9. Agathe Subtil

    Unité de Biologie cellulaire de l'infection microbienne, Institut Pasteur, Paris, France
    For correspondence
    asubtil@pasteur.fr
    Competing interests
    The authors declare that no competing interests exist.

Reviewing Editor

  1. Dominique Soldati-Favre, University of Geneva, Switzerland

Publication history

  1. Received: October 28, 2015
  2. Accepted: March 15, 2016
  3. Accepted Manuscript published: March 16, 2016 (version 1)
  4. Version of Record published: April 8, 2016 (version 2)

Copyright

© 2016, Gehre et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,963
    Page views
  • 740
    Downloads
  • 39
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, Scopus, PubMed Central.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Download citations (links to download the citations from this article in formats compatible with various reference manager tools)

Open citations (links to open the citations from this article in various online reference manager services)

Further reading

    1. Cell Biology
    2. Neuroscience
    Javier Emperador-Melero et al.
    Research Advance

    It has long been proposed that Leukocyte common Antigen-Related Receptor Protein Tyrosine Phosphatases (LAR-RPTPs) are cell-adhesion proteins that control synapse assembly. Their synaptic nanoscale localization, however, is not established, and synapse fine structure after knockout of the three vertebrate LAR-RPTPs (PTPδ, PTPσ and LAR) has not been tested. Here, superresolution microscopy reveals that PTPδ localizes to the synaptic cleft precisely apposed to postsynaptic scaffolds of excitatory and inhibitory synapses. We next assessed synapse structure in newly generated triple-conditional knockout mice for PTPδ, PTPσ and LAR, complementing a recent independent study of synapse function after LAR-RPTP ablation (Sclip and Südhof, 2020). While mild effects on synaptic vesicle clustering and active zone architecture were detected, synapse numbers and their overall structure were unaffected, membrane anchoring of the active zone persisted, and vesicle docking and release were normal. Hence, despite their localization at synaptic appositions, LAR-RPTPs are dispensable for presynapse structure and function.

    1. Cell Biology
    2. Stem Cells and Regenerative Medicine
    Carolina Ortiz-Cordero et al.
    Research Article Updated

    Mutations in the fukutin-related protein (FKRP) cause Walker-Warburg syndrome (WWS), a severe form of congenital muscular dystrophy. Here, we established a WWS human induced pluripotent stem cell-derived myogenic model that recapitulates hallmarks of WWS pathology. We used this model to investigate the therapeutic effect of metabolites of the pentose phosphate pathway in human WWS. We show that functional recovery of WWS myotubes is promoted not only by ribitol but also by its precursor ribose. Moreover, we found that the combination of each of these metabolites with NAD+ results in a synergistic effect, as demonstrated by rescue of α-dystroglycan glycosylation and laminin binding capacity. Mechanistically, we found that FKRP residual enzymatic capacity, characteristic of many recessive FKRP mutations, is required for rescue as supported by functional and structural mutational analyses. These findings provide the rationale for testing ribose/ribitol in combination with NAD+ to treat WWS and other diseases associated with FKRP mutations.